ICD-10-CM Billable Code

J94.1

Fibrothorax

Clinical Classification Guidelines

Medical Intelligence & Overview

Fibrothorax refers to the thickening and scarring of the pleural space, which is the area between the lungs and the chest wall. This condition usually results from previous inflammation or injury to the pleura—the thin membrane surrounding the lungs. Over time, this scarring causes the pleural space to become rigid, restricting lung expansion and impairing breathing. Fibrothorax often develops after infections, trauma, or other respiratory issues that lead to pleural inflammation or bleeding.

Causes & Symptoms

Clinical Causes: Previous bacterial or viral infections of the pleura, such as tuberculosis or pneumonia Chest trauma or injury leading to bleeding or inflammation in the pleural space Complications from thoracic surgeries or invasive procedures Exposure to certain medications or radiation therapy that can cause pleural damage Chronic chemical or asbestos exposure causing pleural irritation and scarring

Key Symptoms: Shortness of breath, especially during physical activity Persistent cough Chest pain or discomfort, which may worsen during deep breaths or coughing Reduced chest expansion on the affected side A feeling of tightness in the chest In some cases, asymptomatic and detected through imaging studies

Diagnostic & Treatment

Diagnosis Path: Diagnosing fibrothorax involves a combination of clinical evaluation and imaging procedures. A healthcare provider may perform a physical exam to assess breath sounds and chest movement. Imaging studies are critical for confirmation: - **Chest X-ray:** Can reveal pleural thickening, calcifications, or loss of lung volume. - **Computed Tomography (CT) Scan:** Provides detailed images of the pleural surfaces and can identify fibrous tissue's extent and location. - **Pleural Fluid Analysis:** If fluid is present, analyzing the fluid can help determine underlying causes. - **Pulmonary Function Tests:** Evaluate the impact on lung capacity and airflow. In some cases, a tissue biopsy might be required to confirm the diagnosis or rule out other conditions.

Treatment Protocols: Treatment strategies depend on the severity and symptoms. Some common approaches include: - **Observation:** Mild cases without significant symptoms may only require regular monitoring. - **Medical Management:** Medications such as anti-inflammatory drugs or antibiotics if an active infection is present. - **Pleurodesis:** A procedure that involves introducing a substance into the pleural space to cause lung and chest wall surfaces to stick together, preventing fluid buildup and further scarring. - **Surgical Intervention:** In cases where fibrothorax significantly impairs breathing, surgery such as thoracotomy or pleurectomy may be necessary to remove scar tissue and improve lung expansion. - **Rehabilitation:** Pulmonary rehabilitation programs can help improve respiratory function and overall quality of life. Early detection and appropriate management are essential for reducing complications and improving outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is J94.1 a billable ICD-10 code?
Yes, J94.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report J94.1?
Clinical documentation must specify the nature of Fibrothorax and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

fibrothorax